The effects of three short-acting neuromuscular blocking agents on fast- and slow-contracting muscles of the cat.
D000731:Androstanes / Q000494:pharmacology; D000818:Animals; D001391:Azo Compounds / Q000494:pharmacology; D002415:Cats; D002800:Cholinesterase Inhibitors / Q000494:pharmacology; D004305:Dose-Response Relationship, Drug; D004491:Edrophonium / Q000494:pharmacology; D005703:Gallamine Triethiodide / Q000494:pharmacology; D007093:Imidazoles / Q000494:pharmacology; D066298:In Vitro Techniques; D008026:Ligation; D009132:Muscles / Q000187:drug effects*; D009388:Neostigmine / Q000494:pharmacology; D009467:Neuromuscular Depolarizing Agents / Q000494:pharmacology*; D003473:Neuromuscular Nondepolarizing Agents / Q000008:administration & dosage / Q000494:pharmacology*; D010880:Piperidines / Q000494:pharmacology; D011245:Pregnadienes / Q000494:pharmacology; D011726:Pyridinium Compounds / Q000494:pharmacology; D011759:Pyrrolidines / Q000494:pharmacology; D000644:Quaternary Ammonium Compounds / Q000494:pharmacology; D012584:Sciatic Nerve / Q000187:drug effects; D014403:Tubocurarine / Q000494:pharmacology
D000731:Androstanes; D001391:Azo Compounds; D002800:Cholinesterase Inhibitors; D007093:Imidazoles; D009467:Neuromuscular Depolarizing Agents; D003473:Neuromuscular Nondepolarizing Agents; D010880:Piperidines; D011245:Pregnadienes; D011726:Pyridinium Compounds; D011759:Pyrrolidines; D000644:Quaternary Ammonium Compounds; D009388:Neostigmine; D004491:Edrophonium; D005703:Gallamine Triethiodide; D014403:Tubocurarine